These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22592694)

  • 1. Totally implantable vascular access devices for cystic fibrosis.
    A-Rahman AK; Spencer D
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD004111. PubMed ID: 22592694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Totally implantable vascular access devices for cystic fibrosis.
    A-Rahman A; Spencer D
    Cochrane Database Syst Rev; 2003; (3):CD004111. PubMed ID: 12918004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis.
    Amin R; Noone PG; Ratjen F
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007481. PubMed ID: 19370689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteral tube feeding for cystic fibrosis.
    Conway SP; Morton A; Wolfe S
    Cochrane Database Syst Rev; 2008 Apr; (2):CD001198. PubMed ID: 18425869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oscillating devices for airway clearance in people with cystic fibrosis.
    Morrison L; Innes S
    Cochrane Database Syst Rev; 2017 May; 5(5):CD006842. PubMed ID: 28471492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
    McIlwaine M; Button B; Dwan K
    Cochrane Database Syst Rev; 2015 Jun; (6):CD003147. PubMed ID: 26083308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oscillating devices for airway clearance in people with cystic fibrosis.
    Morrison L; Milroy S
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD006842. PubMed ID: 32352564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis.
    Amin R; Noone PG; Ratjen F
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD007481. PubMed ID: 23235645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous lines for delivering intravenous antibiotics in people with cystic fibrosis.
    Prayle AP; Hurley MN; Smyth AR
    Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD008243. PubMed ID: 21069703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
    Somaraju UR; Solis-Moya A
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008227. PubMed ID: 27878805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
    Somaraju UR; Solis-Moya A
    Cochrane Database Syst Rev; 2014 Oct; (10):CD008227. PubMed ID: 25310479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
    Ng SM; Moore HS
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD003424. PubMed ID: 27546383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oscillating devices for airway clearance in people with cystic fibrosis.
    Morrison L; Agnew J
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006842. PubMed ID: 25038719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.
    Deerojanawong J; Sawyer SM; Fink AM; Stokes KB; Robertson CF
    Thorax; 1998 Apr; 53(4):285-9. PubMed ID: 9741372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
    Ng SM; Franchini AJ
    Cochrane Database Syst Rev; 2014 Jul; (7):CD003424. PubMed ID: 25019293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Plummer A; Wildman M
    Cochrane Database Syst Rev; 2013 May; (5):CD006682. PubMed ID: 23728662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Plummer A; Wildman M
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006682. PubMed ID: 21249681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
    Fernandes B; Plummer A; Wildman M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006682. PubMed ID: 18425963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
    Smith S; Ratjen F; Remmington T; Waters V
    Cochrane Database Syst Rev; 2020 May; 5(5):CD006961. PubMed ID: 32412092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.